Search Results

Emotional Experience of People With Schizophrenia and People at Risk for Psychosis: A Meta-Analysis.

• Authors : Riehle, Marcel; Straková, Alexandra; Lincoln, Tania M.

Subjects: PEOPLE with schizophrenia; AT-risk people; PSYCHOSES

• Source: JAMA Psychiatry; Jan2024, Vol. 81 Issue 1, p57-66, 10p

Record details

Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial.

• Authors : Kaul, Inder; Sawchak, Sharon; Walling, David P.

Subjects: MUSCARINIC receptors; PEOPLE with schizophrenia; DOPAMINE receptors

• Source: JAMA Psychiatry; Aug2024, Vol. 81 Issue 8, p749-756, 8p

Record details

Schizophrenia Linked With Genetic Changes That Are Not Inherited.

• Authors : Harris, Emily (AUTHOR)

Subjects: SCHIZOPHRENIA; PEOPLE with schizophrenia; DOPAMINERGIC neurons

• Source: JAMA: Journal of the American Medical Association. 8/8/2023, Vol. 330 Issue 6, p496-496. 1p.

Record details

Pneumonia Risk, Antipsychotic Dosing, and Anticholinergic Burden in Schizophrenia.

• Authors : Luykx, Jurjen J.; Correll, Christoph U.; Manu, Peter

Subjects: PROPORTIONAL hazards models; HOSPITAL admission & discharge; PEOPLE with schizophrenia

• Source: JAMA Psychiatry; Oct2024, Vol. 81 Issue 10, p967-975, 9p

Record details

Ethnoracial Risk Variation Across the Psychosis Continuum in the US: A Systematic Review and Meta-Analysis.

• Authors : van der Ven, Els; Olino, Thomas M.; Diehl, Katharina

Subjects: ASIANS; PSYCHOSES; BLACK people

• Source: JAMA Psychiatry; May2024, Vol. 81 Issue 5, p447-455, 9p

Record details

Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With Schizophrenia.

• Authors : Wei Y; Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong Special Administration Region (SAR), China.; Yan VKC

Subjects: Antipsychotic Agents*/Antipsychotic Agents*/Antipsychotic Agents*/adverse effects ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/drug therapy ; Schizophrenia*/Schizophrenia*/Schizophrenia*/drug therapy

• Source: JAMA network open [JAMA Netw Open] 2022 Jul 01; Vol. 5 (7), pp. e2224163. Date of Electronic Publication: 2022 Jul 01.Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic

Record details

Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia: A Systematic Review and Meta-analysis.

• Authors : Hagi K; Medical Affairs, Sumitomo Dainippon Pharma, Tokyo, Japan.; Nosaka T

Subjects: Heart Disease Risk Factors*; Cognitive Dysfunction/Cognitive Dysfunction/Cognitive Dysfunction/*epidemiology ; Diabetes Mellitus/Diabetes Mellitus/Diabetes Mellitus/*epidemiology

• Source: JAMA psychiatry [JAMA Psychiatry] 2021 May 01; Vol. 78 (5), pp. 510-518.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print

Record details

Researchers Focus on Recovery in Schizophrenia.

• Authors : Friedrich, M. J.

Subjects: SCHIZOPHRENIA treatment; PEOPLE with schizophrenia; MENTAL illness

• Source: JAMA: Journal of the American Medical Association. 7/2/2014, Vol. 312 Issue 1, p16-18. 3p.

Record details

ABSTRACTS.

Subjects: PSYCHIATRY; PEOPLE with schizophrenia; NEUROLOGY

• Source: JAMA: Journal of the American Medical Association. 1/2/2008, Vol. 299 Issue 1, p15-17. 3p.

Record details

Associations of the Gut Microbiome With Treatment Resistance in Schizophrenia.

• Authors : Vasileva, Svetlina S.; Yang, Yuanhao; Baker, Andrea

Subjects: GUT microbiome; MULTIVARIATE analysis; PEOPLE with schizophrenia

• Source: JAMA Psychiatry; Mar2024, Vol. 81 Issue 3, p292-302, 11p

Record details